GAP vs REGN
The Gap, Inc. (GAP) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
The Gap, Inc. (GAP) is a apparel retail company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported GAP revenue for 2025-02-01 was $15.09B. Net income was $844.0M. Revenue was up 1.3% from 2024-02-03 to 2025-02-01. GAP currently screens at market cap $7.73B and trailing P/E 9.9.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
GAP currently screens at market cap $7.73B and trailing P/E 9.9. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the GAP and REGN stock pages for the full models.
Not investment advice.